tru Independence’s PetMed Express PETS Stock Holding History

tru Independence’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-150	Closed	-$4	–	913
2020 Q1	$4	Hold	150	–	–	﹤0.01%	563
2019 Q4	$4K	Buy	+150	New	+$3.36K	﹤0.01%	722

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

tru Independence's PETS Position: Q2 2020 in Review

tru Independence sold out of PetMed Express (PETS) in Q2 2020, closing a stake of 150 shares — an estimated $4 sold.

tru Independence first reported a position in PETS in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 222 funds tracked by Wall St. Rank hold PETS as of Q2 2020.

tru Independence reported no remaining PetMed Express position as of Q2 2020 after selling out during the quarter.
tru Independence sold 150 PetMed Express shares in Q2 2020, an estimated $4.
tru Independence first reported a position in PetMed Express in Q4 2019 and held it in 2 quarters.
tru Independence's PetMed Express position peaked at $4K in Q4 2019.
222 funds tracked by Wall St. Rank held PetMed Express as of Q2 2020.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.